Intrinsiqq
SB Technology Holdings, Inc. logo

SB Technology Holdings, Inc. Financials

VGLSD

Compare

All currency values in $ millions unless otherwise noted

Income Statement
TTM
3:1 split
DEC 2014
~3.4:1 split
DEC 2013
Revenues
Revenue$0$0$0
Cost of Revenue$2$2$2
Gross Profit-$2-$2-$2
General & Administrative$1$1$1
Research & Development$0$1$1
Total Operating Expenses$3$4$4
Operating Income-$3-$4-$4
Non-Operating
Net Interest Expense-$2-$3-$1
Other Non-Operating Income (Expense)-$2-$2-$4
Income Tax Expense$0$0$0
Minority Interest-$0-$0-$0
Net Income
Net Income-$4-$6-$7
Per Share Data
Revenue Per Share$0.00$0.00$0.00
EPS (Basic)-$0.02-$0.22-$0.91
EPS (Diluted)-$0.02-$0.22-$0.91
Weighted Avg Shares (Basic)85.5M27.6M8.2M
Weighted Avg Shares (Diluted)85.5M27.6M8.2M
Shares Outstanding85.5M27.6M8.2M

SB Technology Holdings (VGLSD) financials: revenue, profit and margins

SB Technology Holdings (VGLSD) generated about $0.00 in revenue and -$4 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is SB Technology Holdings's (VGLSD) revenue?+

SB Technology Holdings generated about $0.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is SB Technology Holdings profitable?+

SB Technology Holdings reported about -$4 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 19 Nov 2015, covering the period ending 30 Sept 2015, as reported to the SEC. Data last refreshed 25 Jun 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with VGLSD

CompareIntrinsic value
CNBXCnbx Pharmaceuticals Inc.
$0.00+0.00%10
EMMAEmmaus Life Sciences, Inc.
$0.04+52.17%21
GOVXGeovax Labs Inc.
$1.85-3.14%25
SILOSilo Pharma Inc.
$1.73-7.98%10
ABTAbbott Laboratories
$103.00-0.84%29
SKVISkinvisible Inc.
$0.18+0.00%0
JUNSJupiter Neurosciences Inc.
$1.24-15.41%10
LYELLyell Immunopharma, Inc.
$13.80+1.62%10

Held by ETFs

VGLSD is in 1 US ETF. The largest of them, with VGLSD's weight in each:

Spot a number that looks wrong? Check it in VGLSD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing VGLSD

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.